Diabetes Disparities: Texting to Extend Treatment (DD-TXT)
단계 해당 없음
완료
NCT04227379
| 대상 질환 | Diabetes Mellitus, Type 2 |
|---|
| 임상 단계 | 단계 해당 없음 |
|---|
| 스폰서 | VA Office of Research and Development |
|---|
| 상태 | 완료 |
|---|
| 참여자 수 | 366 명 |
|---|
| 중재(약물) | Intervention 1- DSMS+, Comparison - DSMS |
|---|
| 시작일 | 2023년 1월 30일 |
|---|
| 완료일 | 2025년 4월 30일 |
|---|
| 결과 공개일 | 2026년 6월 1일 |
|---|
요약
One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.
Change in HbA1c Percent Time in Control
pre-enrollment, 6 month follow up · percent (%) of time in control
| DSMS | 23.41 ± 34.96 percent (%) of time in control |
|---|
| DSMS+ (DSMS Plus) | 21.61 ± 40.55 percent (%) of time in control |
|---|
| p-value | .6519 |
| Mean Difference (Net) | 1.80 (95% CI -6.05–9.65) |
Change in HbA1c
pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin
| DSMS | -0.36 ± 1.37 Percentage of glycosylated hemoglobin |
|---|
| DSMS+ (DSMS Plus) | -0.40 ± 1.29 Percentage of glycosylated hemoglobin |
|---|
| p-value | .7552 |
| Mean Difference (Net) | .05 (95% CI -.25–.34) |
BENITIONS에서 보기
ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
전체 임상
이 페이지는 ClinicalTrials.gov의 공개 데이터를 정리한 것입니다. 의학적 조언이 아니며 투자 권유나 자문도 아닙니다. 반드시 전문의와 상담하세요.